Contributions of innate immunity to allograft rejectionand survival

Current Opinion in Organ Transplantation

Volumn 8, Issue 1, 2003, Pages 2-6

  Le Moine, Alain ^a   Goldman, Michel ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2542566014     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200303000-00002     Document Type: Review

References (65)

1. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
2. Vivier E, Biron CA: Immunology: a pathogen receptor on natural killer cells. Science 2002, 296:1248-1249.
3. Daemen MA, de Vries B, Buurman WA: Apoptosis and inflammation in renal reperfusion injury. Transplantation 2002, 73:1693-1700.
4. Daemen MA, van 't Veer C, Denecker G, et al.: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999, 104:541-549.
5. Basu S, Binder RJ, Suto R, et al.: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int Immunol 2000, 12:1539-1546.
6. Binder RJ, Anderson KM, Basu S, et al.: Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol 2000, 165:6029-6035.
7. Feeley BT, Miniati DN, Park AK, et al.: Nuclear factor-κB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents. Transplantation 2000, 70:1560-1568.
8. Vos IH, Govers R, Grone HJ, et al.: NF-κB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000, 14:815-822.
9. Lechler R, Ng WF, Steinman RM: Dendritic cells in transplantation-friend or foe? Immunity 2001, 14:357-368.
10. El Sawy T, Fahmy N, Fairchild R: Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002, 14:562.
11. Miura M, Fu X, Zhang QW, et al.: Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 2001, 159:2137-2145.
12. Fisher AJ, Donnelly SC, Hirani N, et al.: Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001, 163:259-265.
13. Gabbay E, Walters EH, Orsida B, et al.: Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med 2000, 162:2182-2187.
14. Warrens AN, Cardozo L, Rouw D, et al.: The influence of the gal epitope on phagocytes in xenotransplantation. Transplantation 2002, 74:S353.
15. Tateda K, Moore TA, Deng JC, et al.: Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J Immunol 2001, 166:3355-3361.
16. Bliss SK, Butcher BA, Denkers EY: Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol 2000, 165:4515-4521.
17. Buonocore S, Paulart F, Le Moine A, et al.: Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T cell responses in vivo. Blood 2002, in press.
18. Nishimura M, Umehara H, Nakayama T, et al.: Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002, 168:6173-6180.
19. Morita K, Miura M, Paolone DR, et al.: Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001, 167:2979-2984.
20. Robinson LA, Nataraj C, Thomas DW, et al.: A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 2000, 165:6067-6072.
21. Haskell CA, Hancock WW, Salant DJ, et al.: Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 2001, 108:679-688.
22. Hancock WW, Gao W, Csizmadia V, et al.: Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001, 193:975-980.
23. Christopher K, Mueller TF, Ma C, et al.: Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 2002, 169:522-530.
24. Grau V, Herbst B, Steiniger B: Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res 1998, 291:117-126.
25. Wilhelm MJ, Pratschke J, Beato F, et al.: Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000, 102:2426-2433.
26. Cecka JM: The UNOS Scientific Renal Transplant Registry 2000. Clin Transpl 2000, 1-18.
27. Burne MJ, Daniels F, El Ghandour A, et al.: Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001, 108:1283-1290.
28. Le Moine O, Louis H, Demols A, et al.: Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 2000, 31:1266-1274.
29. Hancock WW, Lu B, Gao W, et al.: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000, 192:1515-1520.
30. Kobayashi H, Novick AC, Toma H, et al.: Chronic antagonism of MIG inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts. Transplantation 2002, 74:387-395.
31. Belperio JA, Keane MP, Burdick MD, et al.: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002, 169:1037-1049.
32. Miura M, Morita K, Kobayashi H, et al.: Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001, 167:3494-3504.
33. Kapoor A, Morita K, Engeman TM, et al.: Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells. Transplantation 2000, 69:1147-1155.
34. Graca L, Cobbold SP, Waldmann H: Identification of regulatory T cells in tolerated allografts. J Exp Med 2002, 195:1641-1646.
35. Regele H, Bohmig GA, Habicht A, et al.: Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002, 13:2371-2380.
36. Sumitran-Holgersson S, Wilczek HE, Holgersson J, et al.: Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002, 74:268-277.
37. Mauiyyedi S, Crespo M, Collins AB, et al.: Acute humoral rejection in kidney transplantation, II: morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002, 13:779-787.
38. Mauiyyedi S, Pelle PD, Saidman S, et al.: Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001, 12:574-582.
39. Fleming SD, Shea-Donohue T, Guthridge JM, et al.: Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 2002, 169:2126-2133.
40. Rehrig S, Fleming SD, Anderson J, et al.: Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J Immunol 2001, 167:5921-5927.
41. Baldwin WM III, Larsen CP, Fairchild RL: Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001, 14:369-376.
42. Du Clos TW: Function of C-reactive protein. Ann Med 2000, 32:274-278.
43. Collard CD, Vakeva A, Morrissey MA, et al.: Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000, 156:1549-1556.
44. Weiser MR, Williams JP, Moore FD Jr, et al.: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996, 183:2343-2348.
45. Baldwin WM III, Samaniego-Picota M, Kasper EK, et al.: Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 1999, 68:894-900.
46. Haas M, Ratner LE, Montgomery RA: C4d staining of perioperative renal transplant biopsies. Transplantation 2002, 74:711-717.
47. Bohmig GA, Exner M, Habicht A, et al.: Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J AM Soc Nephrol 2002, 13: 1091-1099.
48. Bajtay Z, Jozsi M, Banki Z, et al.: Mannan-binding lectin and C1q bind to distinct structures and exert differential effects on macrophages. Eur J Immunol 2000, 30:1706-1713.
49. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8:582-587.
50. Qian Z, Hu W, Liu J, et al.: Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries. Transplantation 2001, 72:900-906.
51. Hancock WW, Gao W, Shemmeri N, et al.: Immunopathogenesis of accelerated allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms. Transplantation 2002, 73:1392-1397.
52. Colucci F, Di Santo JP, Leibson PJ: Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol 2002, 3:807-813.
53. Velardi A, Ruggeri L, Alessandro, et al.: NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002, 23:438.
54. Umehara H, Bloom E, Okazaki T, et al.: Fractalkine and vascular injury. Trends Immunol 2001, 22:602-607.
55. Yoneda O, Imai T, Goda S, et al.: Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 2000, 164:4055-4062.
56. Russell PS, Chase CM, Sykes M, et al.: Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001, 167:5731-5740.
57. Maier S, Tertilt C, Chambron N, et al.: Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001, 7:557-562.
58. Kondo T, Morita K, Watarai Y, et al.: Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000, 69:969-977.
59. Zitvogel L: Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002, 195:F91-F94.
60. Piccioli D, Sbrana S, Melandri E, et al.: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002, 195:335-341.
61. Gerosa F, Baldani-Guerra B, Nisii C, et al.: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333.
62. Seino KI, Fukao K, Muramoto K, et al.: Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001, 98:2577-2581.
63. Skelsey ME, Mellon J, Niederkorn JY: Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol 2001, 166:4327-4333.
64. Okabe K, Yamaguchi Y, Takai E, et al.: CD45RC gammadelta T-cell infiltration is associated with immunologic unresponsiveness induced by prior donorspecific blood transfusion in rat hepatic allografts. Hepatology 2001, 33:877-886.
65. Gorczynski RM, Chen Z, Kai Y, et al.: Evidence for persistent expression of OX2 as a necessary component of prolonged renal allograft survival following portal vein immunization. Clin Immunol 2000, 97:69-78.